ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 110383 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 110383; 2) Community: the network communities that were significantly associated with the response to NSC 110383; 3) Molecule: the relationships between components within communities and NSC 110383; 4) MDR: the compounds that were significantly associated with the NSC 110383.

NSC Compound Enrichment Correlation
NSC 676676 ARQ monoacetate 0.0385203205529756 0.1712409
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.0385203205529756 -0.18052913
NSC 679600 Null 0.0385203205529756 0.0019550336
NSC 682298 Camptothecin Derivative 0.0385203205529756 -0.010641629
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0385203205529756 -0.12732018
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.0385203205529756 -0.10203436
NSC 691767 Null 0.0385203205529756 0.43449897
NSC 691778 Null 0.0385203205529756 -0.026017899
NSC 692581 Null 0.0385203205529756 -0.13414031
NSC 694269 Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate 0.0385203205529756 -0.098568296
Total:104  Current:79    [First] [Prev] [Next] [Last]